Evidence map›Paper›PMID 39706340›Full record

ArticleVirologica Sinica2025

Gene flow and its sporadic spillover: H10 and N5 avian influenza viruses from wild birds and the H10N5 human cases in China.

Weijie Chen, Shuiping Lu, Haiyan Xiong, Zhiyu Xiang, Yuxi Wang, Jingjing Hu, Yue Pan, Yanjiao Li, Qile Gao, Qi Chen and 3 more

Abstract read
In one paragraph

Article in Virologica Sinica, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 4 papers.

0numbers the graph read from it
0cells of the map it votes in
4citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

4 citing papers in PubMed.

  1. Article
  2. Article
  3. Article
  4. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Weijie ChenSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Shuiping LuSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Haiyan XiongSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Zhiyu XiangDepartment of Clinical Medicine, Shanghai Medical College, Fudan University, Shanghai 200032, China.
Yuxi WangSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Jingjing HuShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200433, China; Innostellar Biotherapeutics Co. Ltd., Shanghai 201203, China.
Yue PanSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Yanjiao LiSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Qile GaoSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Qi ChenShanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200433, China.
Siru HuSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China.
Weibing WangSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China; Shanghai Institute of Infectious Disease and Biosecurity, Fudan University, Shanghai 200433, China. Electronic address: wwb@fudan.edu.cn.
Chenglong XiongSchool of Public Health, Fudan University, Key Lab of Public Health Safety, Ministry of Education, Shanghai 200433, China. Electronic address: xiongchenglong@fudan.edu.cn.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

On January 30, 2024, China announced the first human case of H10N5 influenza infection. Prior to this, human cases of H10N7 and H10N8 had been reported. It is now appropriate to re-examine the evolution and future epidemiological trends of the H10 and N5 subtypes of avian influenza viruses (AIVs). In this study, we analyzed the reassortment characteristics of the first human-derived H10N5 AIV (A/Zhejiang/ZJU01/2023), as well as the evolutionary dynamics of the wild bird-derived H10 and N5 subtypes of AIVs over the past decade. Our findings indicate that the human-derived H10N5 AIV exhibited low pathogenicity. A/bean_goose/Korea/KNU-10/2022(H10N7) and A/mallard/Novosibirsk_region/962k/2018(H12N5) were identified as the potential reassortment parents. The virus has existed since 2022 and several isolations have been reported in Bangladesh. Phylogenetic analysis showed that H10Ny and HxN5 AIVs in China are clustered differently based on the East Asian-Australian (eastern) and Central Asian-Indian (western) migratory flyways. The H10Ny and HxN5 AIV reassortant strains may cause human infections through accidental spillover. It is possible that another center of AIV evolution, mutation, and reassortment may be developing along the migratory flyways in northeastern Asia, distinct from Europe, the Americas, and China's Yangtze River Delta and Pearl River Delta, which should be closely monitored to ensure the safety of the public.

Indexed as

Animals, WildGene FlowInfluenza A virusInfluenza, HumanInfluenza in BirdsAnimalsBirdsChinaEvolution, MolecularHumansPhylogenyReassortant VirusesAvian influenza virus (AIV)EvolutionH10N5Migration flywayReassortment

Identifiers

PMID39706340
PMCPMC11963014

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.